N. Campos

发表

Different human papillomavirus types share early natural history transitions in immunocompetent women

P. Castle, A. Rodriguez, M. Schiffman, 2022, International journal of cancer.

Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.

M. Gail, D. Lowy, J. Sampson, 2021, Vaccine.

Reproducible And Clinically Translatable Deep Neural Networks For Cervical Screening

S. Antani, Jayashree Kalpathy-Cramer, M. Schiffman, 2022, medRxiv.

New Malaise: Bioethics and Human Rights in the Global Era

P. Farmer, Nicole G. Campos, N. Campos, 2004, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

Rethinking medical ethics: a view from below.

P. Farmer, Nicole G. Campos, N. Campos, 2004, Developing world bioethics.

Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.

K. Freedberg, J. Salomon, S. Goldie, 2007, The American journal of medicine.

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador

P. Castle, Jane J. Kim, J. Felix, 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis

S. Resch, Jane J. Kim, V. Tsu, 2018, International journal of cancer.

Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial

J. Singer, H. Armstrong, Jane J. Kim, 2018, BMJ Open.

Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study

Jane J. Kim, Mercy Mvundura, V. Tsu, 2017, BMC Cancer.

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua

Jane J. Kim, Mercy Mvundura, E. Vodicka, 2017, BMJ Open.

The comparative and cost‐effectiveness of HPV‐based cervical cancer screening algorithms in El Salvador

P. Castle, Jane J. Kim, J. Felix, 2015, International journal of cancer.

Claims for Missing or Damaged Print Issues

D. Milner, G. Clifford, Z. Xue, 2021 .

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.

S. Goldie, Sun-young Kim, M. Diaz, 2008, Vaccine.

Evidence‐based policy choices for efficient and equitable cervical cancer screening programs in low‐resource settings

Jane J. Kim, Mercy Mvundura, V. Tsu, 2017, Cancer medicine.

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus

Jane J. Kim, E. Burger, S. Sy, 2017, Journal of the National Cancer Institute.

Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta

P. Castle, I. Scarinci, Jane J. Kim, 2021, Cancer Epidemiology, Biomarkers & Prevention.

A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer.

Kanan T. Desai, M. Schiffman, L. Bruni, 2021, Preventive medicine.

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control

J. Berkhof, M. Jit, S. Kulasingam, 2019, Papillomavirus research.

Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study

P. Michelow, Jennifer S. Smith, Jane J. Kim, 2018, Journal of acquired immune deficiency syndromes.

The Value of Different Types of Economic and Budget Analysis for Informing Real World Decision Making: the Case of Cervical Cancer Screening in South Africa

J. Miot, G. Meyer-Rath, N. Lince-Deroche, 2020 .

When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysis

Jane J. Kim, Mercy Mvundura, V. Tsu, 2015, Papillomavirus Research.

Partners: Discernment and Humanitarian Efforts in Settings of Violence

P. Farmer, Nicole G. Campos, N. Campos, 2003, Journal of Law, Medicine & Ethics.

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

Jane J. Kim, E. Burger, S. Sy, 2018, Vaccine.

The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing

Paul C. Pearlman, Kanan T. Desai, S. Antani, 2021, International journal of cancer.

Secondary Prevention of Cervical Cancer: ASCO Resource–Stratified Guideline Update

S. Temin, Y. Woo, Youlin Qiao, 2022, JCO global oncology.

The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.

P. Castle, T. Alonzo, Jane J. Kim, 2019, Preventive medicine.

Cost‐effectiveness of cervical cancer screening methods in low‐ and middle‐income countries: A systematic review

S. Bryan, H. Armstrong, Jane J. Kim, 2017, International journal of cancer.

The Cost-Effectiveness of Visual Triage of Human Papillomavirus–Positive Women in Three Low- and Middle-Income Countries

P. Castle, Jane J. Kim, Mercy Mvundura, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting

Jane J. Kim, Mercy Mvundura, V. Tsu, 2017, Health policy and planning.

To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low‐resource settings

Jane J. Kim, Mercy Mvundura, V. Tsu, 2017, International journal of cancer.

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa

P. Castle, S. Goldie, Jane J. Kim, 2012, International journal of cancer.

Comprehensive Global Cervical Cancer Prevention Costs and Benefits of Scaling up within a Decade

S. Resch, Jane J. Kim, Monisha Sharma, 2022 .

Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.

Jane J. Kim, M. Diaz, I. Mutyaba, 2013, Vaccine.

Cancer Screening Utilization Among Immigrant Women in Miami, Florida

O. Carrasquillo, S. McCann, Julia Seay, 2015, Progress in community health partnerships : research, education, and action.

Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi‐eligible countries

Jane J. Kim, E. Burger, A. Portnoy, 2020, International journal of cancer.

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.

J. Cuzick, C. Wheeler, A. Waxman, 2015, Annals of internal medicine.

An updated natural history model of cervical cancer: derivation of model parameters.

Allan Hildesheim, Stephen Sy, Rolando Herrero, 2014, American journal of epidemiology.

Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action

T. Koru-Sengul, J. Kish, Nicole G. Campos, 2012, Journal of oncology.

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs

M. Schiffman, P. Castle, T. Raine-Bennett, 2020, EClinicalMedicine.

Cervical cancer screening in low‐resource settings: A cost‐effectiveness framework for valuing tradeoffs between test performance and program coverage

T. Wright, P. Castle, Jane J. Kim, 2015, International journal of cancer.

Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.

P. Castle, I. Scarinci, Jane J. Kim, 2020, Preventive medicine.

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.

Jane J. Kim, E. Burger, Nicole G. Campos, 2017, Journal of the National Cancer Institute.

A case study and proposal for publishing directed acyclic graphs: The effectiveness of the quadrivalent human papillomavirus vaccine in perinatally HIV Infected girls.

Michelle R. Caunca, A. Moscicki, Jamie A. Cohen, 2022, Journal of clinical epidemiology.

The health and economic impact of scaling cervical cancer prevention in 50 low‐ and lower‐middle‐income countries

S. Resch, Jane J. Kim, C. Regan, 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior.

A. Youk, A. Burke, R. Viscidi, 2020, The Journal of infectious diseases.

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries

S. Resch, Jane J. Kim, Monisha Sharma, 2016, PloS one.

Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S.

C. Wheeler, P. Castle, Jane J. Kim, 2018, Preventive Medicine.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study

Oguzhan Alagoz, Ann G Zauber, Iris Lansdorp-Vogelaar, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns

Jane J. Kim, Jamie A. Cohen, E. Burger, 2019, Cancer Epidemiology, Biomarkers & Prevention.

Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study.

S. Wacholder, P. Castle, R. Burk, 2011, The Journal of infectious diseases.

Use of risk-based cervical screening programs in resource-limited settings.

Jayashree Kalpathy-Cramer, S. de Sanjosé, A. Rodriguez, 2023, Cancer epidemiology.

Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting

Jane J. Kim, Mercy Mvundura, V. Tsu, 2017, Health policy and planning.

Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study

B. Graubard, A. Chaturvedi, H. Katki, 2023, Journal of the National Cancer Institute.

A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15‐year cervical cancer screening experience at Kaiser Permanente Northern California

M. Schiffman, P. Castle, T. Lorey, 2020, International journal of cancer.

REPRODUCIBLE AND CLINICALLY TRANSLATABLE DEEP NEURAL NETWORKS FOR CANCER SCREENING

Kanan T. Desai, S. Antani, Jayashree Kalpathy-Cramer, 2023, Research square.

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.

S. Goldie, Sun-young Kim, Steven Sweet, 2008, Vaccine.

Potential Benefits of Second-Generation Human Papillomavirus Vaccines

Jane J. Kim, S. Kiatpongsan, Nicole G. Campos, 2012, PloS one.

Cervical cancer screening in low‐resource settings: A cost‐effectiveness framework for valuing tradeoffs between test performance and program coverage

T. Wright, P. Castle, Jane J. Kim, 2015, International journal of cancer.

Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States.

J. C. Spencer, E. Burger, S. Sy, 2023, Journal of the National Cancer Institute. Monographs.

Potential effectiveness of a therapeutic HPV intervention campaign in Uganda

Jane J. Kim, E. Burger, Nicole G. Campos, 2021, International journal of cancer.

Reproducible and clinically translatable deep neural networks for cervical screening

S. Antani, Jayashree Kalpathy-Cramer, M. Schiffman, 2022, medRxiv.